• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.

     

    Find out more about it and REGISTER today!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult.

    Find out more info and deadline dates

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Update in Chronic Kidney Disease Management and Prescribing"

    (session captured at the GAPNA 2018 Annual Conference)


    For January/February 2020 - Get Your Free CNE Now!

  • Online CEThe Best of 2019!

    A LIVE rebroadcast event featuring 5 of GAPNA's Best CE sessions from 2019

    January 21, 2020 from 11:30 am - 5:15 pm EST

    $39 for GAPNA Members $59 for Non-Members

     

    Register Now

Risk of Death Increases in Nursing Home Residents After Exposure to Typical Antipsychotics

Older antipsychotic medications, called typical antipsychotics, can cause a variety of central nervous system side effects.

The newer, atypical agents are preferred by many due to their better side effect profiles. Typical antipsychotics can increase the risk for mortality in the elderly, conclude researchers.

Researchers analyzed Medicare and Medicaid data on 3,609 typical antipsychotic users matched with 3,609 atypical antipsychotic users. Residents who used atypical antipsychotics had an unadjusted mortality rate of 18.42% compared with 24.06% for users of typical antipsychotics. On average, there was a 41% higher risk of death within 180 days of exposure to typical agents compared to treatment with atypical agents.

The researchers advise physicians to base their decisions to use antipsychotics in this population on individual risk factors as well as the acute and long-term risks of therapy. Since dual-eligible residents are particularly vulnerable, they should be closely monitored once antipsychotic treatment is started.

For more info, see Aparasu et al. (2012). Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Medical Care, 50(11), 961-968. doi:10.1097/MLR.0b013e31826ec185

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: